Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Over the last 12 months, insiders at Globus Medical, Inc. have bought $0 and sold $6.35M worth of Globus Medical, Inc. stock.
On average, over the past 5 years, insiders at Globus Medical, Inc. have bought $49,912 and sold $19.57M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 615 shares for transaction amount of $33,136 was made by Douglas Robert Andrew (director) on 2020‑08‑24.
2024-05-10 | Sale | Lemaitre Dan | director | 63,300 0.0468% | $64.61 | $4.09M | +2.24% | |
2024-05-08 | Sale | Davidar David D | director | 20,000 0.0156% | $65.00 | $1.3M | +7.22% | |
2024-03-15 | Sale | Norwalk Leslie V | director | 10,590 0.0079% | $51.99 | $550,574 | +4.34% | |
2024-03-01 | Sale | Huller Kelly | SVP, GC, Corporate Secretary | 7,500 0.0055% | $54.10 | $405,730 | -0.15% | |
2023-05-15 | Sale | Lemaitre Dan | director | 43,450 0.0436% | $56.98 | $2.48M | -6.09% | |
2023-02-02 | Sale | Pfeil Keith W | SVP, Chief Financial Officer | 29,167 0.0287% | $77.57 | $2.26M | -30.27% | |
2022-12-01 | Sale | Huller Kelly | SVP, GC, Corporate Secretary | 7,500 0.0074% | $75.00 | $562,501 | -24.68% | |
2022-04-19 | Sale | Davidar David D | 31,500 0.031% | $78.03 | $2.46M | -20.94% | ||
2022-04-08 | Sale | Huller Kelly | SVP, GC, Corporate Secretary | 2,500 0.0025% | $75.58 | $188,963 | -17.58% | |
2022-03-15 | Sale | TOBIN JAMES R | 8,850 0.0087% | $65.47 | $579,418 | -2.35% | ||
2022-03-08 | Sale | TOBIN JAMES R | 4,484 0.0045% | $72.00 | $322,848 | -7.13% | ||
2021-08-19 | Sale | Pfeil Keith W | SVP, Chief Financial Officer | 833 0.0008% | $76.13 | $63,416 | -11.03% | |
2021-08-02 | Sale | Pfeil Keith W | SVP, Chief Financial Officer | 833 0.0008% | $83.24 | $69,339 | -15.73% | |
2021-07-19 | Sale | Pfeil Keith W | SVP, Chief Financial Officer | 834 0.0008% | $78.25 | $65,261 | -9.40% | |
2021-07-02 | Sale | Scavilla Daniel T | EVP, Chief Commercial Officer | 100,000 0.0985% | $78.41 | $7.84M | -8.33% | |
2021-07-01 | Sale | Pfeil Keith W | SVP, Chief Financial Officer | 833 0.0008% | $77.43 | $64,499 | -8.12% | |
2021-06-25 | Sale | Pfeil Keith W | SVP, Chief Financial Officer | 27,479 0.0265% | $75.04 | $2.06M | -6.07% | |
2021-05-10 | Sale | TOBIN JAMES R | director | 25,000 0.0252% | $71.96 | $1.8M | +2.93% | |
2021-05-05 | Sale | Pfeil Keith W | SVP, Chief Financial Officer | 5,021 0.0051% | $75.00 | $376,575 | -0.25% | |
2021-04-26 | Sale | Demski David M | President, CEO | 144,263 0.1436% | $71.50 | $10.31M | +2.48% |
Davidar David D | 566275 0.4364% | $68.06 | 0 | 19 | ||
Norwalk Leslie V | director | 17419 0.0129% | $68.06 | 0 | 1 | |
Lemaitre Dan | director | 0 0.0078% | $68.06 | 0 | 3 | |
Huller Kelly | SVP, GC, Corporate Secretary | 0 0% | $68.06 | 0 | 11 | |
Clarus Lifesciences I, L.P. | 10 percent owner | 7244201 5.2573% | $68.06 | 0 | 1 | |
WHEELER KURT | director | 44319 0.0322% | $68.06 | 0 | 3 | |
Murphy A Brett | Group President, Commerical Op | 35217 0.0256% | $68.06 | 0 | 8 | |
LIPTAK ROBERT | director | 26159 0.019% | $68.06 | 0 | 4 | |
Douglas Robert Andrew | director | 2005 0.0015% | $68.06 | 3 | 0 | +25.46% |
Paul David C | Executive Chairman | 0 0% | $68.06 | 0 | 9 | |
Payne Steven | Chief Accounting Officer | 0 0% | $68.06 | 0 | 5 | |
Pfeil Keith W | SVP, Chief Financial Officer | 0 0% | $68.06 | 0 | 7 | |
Schwartz Eric | Senior VP and General Counsel | 0 0% | $68.06 | 0 | 2 | |
TOBIN JAMES R | 0 0% | $68.06 | 0 | 7 | ||
Demski David M | President, CEO | 0 0% | $68.06 | 0 | 25 | |
BARON RICHARD A | Senior VP and CFO | 0 0% | $68.06 | 0 | 1 | |
Scavilla Daniel T | EVP, Chief Commercial Officer | 0 0% | $68.06 | 0 | 4 | |
Williams Anthony L | President | 0 0% | $68.06 | 0 | 6 |
The Vanguard Group | $587.61M | 8.11 | 10.95M | -2.86% | -$17.33M | 0.01 | |
BlackRock | $583.78M | 8.06 | 10.88M | +0.38% | +$2.22M | 0.01 | |
Janus Henderson | $411.01M | 5.67 | 7.66M | -3.12% | -$13.22M | 0.22 | |
State Street | $191.9M | 2.65 | 3.58M | +1.09% | +$2.07M | 0.01 | |
Wellington Management Company | $174.32M | 2.41 | 3.25M | +11.58% | +$18.1M | 0.03 | |
BNY Mellon | $161.82M | 2.23 | 3.02M | +3.82% | +$5.95M | 0.03 | |
Champlain Investment Partners, LLC | $134.34M | 1.85 | 2.5M | +25.18% | +$27.02M | 0.77 | |
Camber Capital Management Lp | $134.1M | 1.85 | 2.5M | +11.11% | +$13.41M | 4.73 | |
Burgundy Asset Management Ltd | $133.02M | 1.84 | 2.48M | +46.08% | +$41.96M | 1.37 | |
Hawk Ridge Capital Management | $126.96M | 1.75 | 2.37M | New | +$126.96M | 5.72 | |
William Blair Investment Management | $119.99M | 1.66 | 2.24M | -2.46% | -$3.02M | 0.31 | |
OZ MANAGEMENT LLC | $118.58M | 1.64 | 2.21M | +204.2% | +$79.6M | 1.71 | |
JPMorgan Chase | $113.29M | 1.56 | 2.11M | +4.84% | +$5.23M | 0.01 | |
Geode Capital Management | $101.35M | 1.4 | 1.89M | -2.9% | -$3.02M | 0.01 | |
GW&K Investment Management | $93.69M | 1.29 | 1.75M | -0.76% | -$715,017.64 | 0.83 | |
Magnetar Capital | $90.61M | 1.25 | 1.69M | +198.59% | +$60.27M | 2.54 | |
Geneva Capital Management LLC | $84.32M | 1.16 | 1.57M | +10.55% | +$8.05M | 1.48 | |
Van Berkom Associates Inc | $82.73M | 1.14 | 1.54M | -2.19% | -$1.86M | 2.36 | |
AXA | $78.89M | 1.09 | 1.47M | +13.4% | +$9.32M | 0.24 | |
Dimensional Fund Advisors | $74.65M | 1.03 | 1.39M | -23.45% | -$22.87M | 0.02 | |
Marshall Wace | $65.95M | 0.91 | 1.23M | -24.79% | -$21.73M | 0.08 | |
The Manufacturers Life Insurance Company | $61.9M | 0.86 | 1.15M | +4.68% | +$2.77M | 0.06 | |
T. Rowe Price | $61.78M | 0.85 | 1.15M | +7.66% | +$4.4M | 0.01 | |
Paradigm Capital Management Inc Ny | $54.25M | 0.75 | 1.01M | +1.98% | +$1.05M | 2.6 | |
Charles Schwab | $52.81M | 0.73 | 984,530 | -2.31% | -$1.25M | 0.01 | |
Vaughan Nelson Investment Management | $51.71M | 0.71 | 964,092 | +25.34% | +$10.45M | 0.45 | |
Global Alpha Capital Management Ltd. | $49.76M | 0.69 | 927,741 | +27.38% | +$10.7M | 3.7 | |
Macquarie Group | $44.63M | 0.62 | 831,946 | +5.11% | +$2.17M | 0.04 | |
Allspring Global Investments | $43.08M | 0.6 | 803,108 | -20.56% | -$11.15M | 0.07 | |
Boston Trust Walden Corp | $40.16M | 0.55 | 748,738 | -0.17% | -$68,820.12 | 0.29 | |
Northern Trust | $39.54M | 0.55 | 737,137 | -12.81% | -$5.81M | 0.01 | |
Stephens Investment Management Group LLC | $39.32M | 0.54 | 733,071 | -0.15% | -$57,823.92 | 0.52 | |
Two Sigma Advisers LP | $39.21M | 0.54 | 730,975 | -7.75% | -$3.29M | 0.07 | |
Bank of America | $39.01M | 0.54 | 727,196 | -45.06% | -$31.99M | <0.01 | |
Morgan Stanley | $38.41M | 0.53 | 715,984 | +3.57% | +$1.32M | <0.01 | |
Two Sigma | $38.26M | 0.53 | 713,315 | -2.36% | -$926,523.73 | 0.07 | |
Madison Avenue Partners, LP | $37.72M | 0.52 | 703,276 | New | +$37.72M | 6.18 | |
Royal Bank of Canada | $36.8M | 0.51 | 686,026 | -14.62% | -$6.3M | 0.01 | |
Grantham Mayo Van Otterloo & Co LLC | $35.73M | 0.49 | 666,053 | +77.8% | +$15.63M | 0.13 | |
Paradice Investment Management | $34.39M | 0.48 | 641,061 | -15.85% | -$6.48M | 5.97 | |
Thrivent Financial For Lutherans | $33.99M | 0.47 | 633,641 | +133.26% | +$19.42M | 0.07 | |
Pembroke Management | $33.61M | 0.46 | 626,601 | +5.15% | +$1.65M | 4.05 | |
State of Wisconsin Investment Board | $32.15M | 0.44 | 599,312 | -3.43% | -$1.14M | 0.08 | |
Bellevue Group | $31.11M | 0.43 | 579,898 | -4.59% | -$1.5M | 0.48 | |
Capital World Investors | $30.82M | 0.43 | 574,500 | 0% | +$0 | 0.01 | |
Citadel Advisors LLC | $30.68M | 0.42 | 571,929 | +423.94% | +$24.82M | 0.02 | |
Boone Capital Management Llc | $28.42M | 0.39 | 529,825 | 0% | +$0 | 5.75 | |
Fort Washington Investment Advisors Inc Oh | $27.3M | 0.38 | 508,874 | -1.04% | -$288,261.36 | 0.18 | |
Clearline Capital LP | $25.83M | 0.36 | 481,604 | +41.05% | +$7.52M | 2.55 | |
Barclays | $25.36M | 0.35 | 472,727 | -9.33% | -$2.61M | 0.01 |